NCT05796531 Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization
| NCT ID | NCT05796531 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Franciscan Hospital For Children, INC. |
| Condition | Self-Injurious Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 155 participants |
| Start Date | 2023-03-31 |
| Primary Completion | 2026-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 155 participants in total. It began in 2023-03-31 with a primary completion date of 2026-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Suicide is the 2nd leading cause of death among adolescents, with the highest risk period for suicide being the month following psychiatric inpatient hospitalization. The investigators propose testing a brief, scalable intervention using evaluative conditioning aimed at reducing suicidal thoughts and behaviors among adolescents during and after inpatient hospitalization. Scalable interventions, such as the one proposed that reduce suicide risk during this markedly high-risk period, could result in large-scale decreases in suicide death.
Eligibility Criteria
Inclusion Criteria: * Be a patient on McLean-Franciscan Child and Adolescent Inpatient Program (MF-CAIP) of Franciscan Children's (FC) * Be 12-19 years-old * Own a smartphone * Have a parent/guardian that can provide permission * Child can assent * Presentation to the hospital with non-suicidal self-injury (NSSI), suicidal ideation or a suicide attempt. Exclusion Criteria: * Any factor that impairs an individual's ability to comprehend and effectively participate in the study, including * an inability to speak or write English fluently * the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, etc., or the presence of extremely agitated or violent behavior * a potential discharge location anticipated to be a residential program in which the average length of stay is more than 14 days
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05796531 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 19 Years, studying Self-Injurious Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05796531 currently recruiting?
Yes, NCT05796531 is actively recruiting participants. Contact the research team at kzuromski@franciscanchildrens.org for enrollment information.
Where is the NCT05796531 trial being conducted?
This trial is being conducted at Brighton, United States.
Who is sponsoring the NCT05796531 clinical trial?
NCT05796531 is sponsored by Franciscan Hospital For Children, INC.. The trial plans to enroll 155 participants.